Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (11)

  1. 1. Kourie Hampig, R., Ameye, L., Paesmans, M., & Bron, D. (2017). Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta-analysis. British journal of haematology, 179(5), 846-848. doi:10.1111/bjh.14259
  2. 2. Demeestere, I., Brice, P., Peccatori, F. A., Kentos, A., Gaillard, I., Zachée, P., Casasnovas, R. O., Van Den Neste, E., Dechene, J., De Maertelaer, V., Bron, D., & Englert, Y. (2017). Reply to M. Lambertini et al. Journal of clinical oncology, 35(7), 805-806. doi:10.1200/JCO.2016.70.6093
  3. 3. Kourie Hampig, R., Ameye, L., Paesmans, M., & Bron, D. (2016). Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis. Annals of hematology, 95(12), 2105-2106. doi:10.1007/s00277-016-2830-8
  4. 4. Servais, S., Baudoux, E., Brichard, B., Bron, D., Debruyn, C., Hemptinne, D. D., Deneys, V., Paulus, J. M., Schaaps, J. J., Van Cauwenberge, J. R., Seidel, L., Delforge, A., & Beguin, Y. (2015). Circadian and circannual variations in cord blood hematopoietic cell composition. Haematologica, 100(1), e32-e34. doi:10.3324/haematol.2014.115394
  5. 5. Demeestere, I., Brice, P., Peccatori, F. A., Kentos, A., Gaillard, I., Zachée, P., Casasnovas, O., Van Den Neste, E., Dechene, J., De Maertelaer, V., Bron, D., & Englert, Y. (2013). Reply to Z. Blumenfeld. Journal of clinical oncology, 31(29), 3722-3723. doi:10.1200/JCO.2013.50.7129
  6. 6. Demeestere, I., Brice, I., Peccatori, F. A., Kentos, A., Gaillard, I., Zachée, P., Casasnovas, O., Van Den Neste, E., De Maertelaer, V., Bron, D., & Englert, Y. (2013). Does Gonadotropin-releasing hormone agonists prevent, chemotherapy induced premature ovarian failure in women with malignant lymphoma?
  7. 7. Meuleman, N., Tondreau, T., Bron, D., & Lagneaux, L. (2007). Human marrow mesenchymal stem cell culture: Serum-free medium allows better expansion than classical alpha-minimal essential medium (MEM) [2]. European journal of haematology, 78(2), 168. doi:10.1111/j.1600-0609.2006.00795.x
  8. 8. Bron, D. (2002). Treating anemia-associated fatigue enabled a patient to receive optimal anti-tumour therapy: Case Report. In Anemia in Cancer 70-71.
  9. 9. Roufosse, C., Lespagnard, L., Sales, F., Bron, D., & Dargent, J.-L. (1998). Langerhans' cell histiocytosis associated with simultaneous lymphocyte predominance Hodgkin's disease and malignant melanoma. Human pathology, 29(2), 200-201. doi:10.1016/S0046-8177(98)90236-2
  10. 10. Aoun, M., Jacquy, C., Debusscher, L., Bron, D., Lehert, M., Noël, P., & Van Der Auwera, P. (1992). Peripheral neuropathy associated with fluoroquinolones [30]. Lancet, 340(8811), 127.
  11. 11. Meunier, F., Aoun, M., & Bron, D. (1989). Prophylaxis of bacterial infections with netilmicin and spiramycin in granulocytopenic patients. European Journal of Clinical Microbiology and Infectious Diseases, 8(10), 927-928.
  12.   Participations à des congrès et colloques internationaux (42)

  13. 1. Michiels, S., Bron, D., Crombez, P., Meuleman, N., Kirakoya, F., & Tricas-Sauras, S. (2019). A prospective approach of migrants and ethnic minorities in order to overcome poor adherence and to guarantee an equal access to innovative transplant procedures. In S. Michiels, D. Bron, P. Crombez, N. Meuleman, F. Kirakoya, & S. Tricas-Sauras (Eds.), NO009 A prospective approach of migrants and ethnic minorities in order to overcome poor adherence and to guarantee an equal access to innovative transplant procedures: Vol. 54 (p. 620–634) Bone Marrow Transplantation.

  14. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37
    38 Suivant >>